Nomura Holdings Inc Bluebird Bio, Inc. Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $310,944 - $431,361	-4,100 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $264,204 - $426,851	4,100 New	4,100 $648,000
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $142,684 - $182,708	-1,432 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$105.8 - $150.94 $26.5 Million - $37.7 Million	-250,000 Reduced 99.43%	1,432 $245,000
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $151,505 - $216,146	1,432 Added 0.57%	251,432 $44.8 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $20.3 Million - $32.7 Million	250,000	250,000 $44.5 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.